Item 1.01 Entry into a Material Definitive Agreement
On May 19, 2021, CannaPharmaRX (the "Company") entered into a Consulting and
Broker Agreement (the "Agreement") with K&K Consultants, Ltd. ("K&K"). The
material terms of the Agreement provide that K&K agrees to identify prospective
business clients and act as an intermediary broker for the Company's products.
In return, the Company will pay K&K a five percent (5%) fee of net value of
product purchased or sold by the Company as a result of K&K's introduction. This
Agreement is to remain effective for a one (1) year period. The Agreement shall
be renewed automatically on a year-to-year basis. This agreement can be
terminated within thirty (30) days notice.
The Agreement is incorporated herein as if set forth as Exhibit 10.X.
Item 7.01 Regulation FD Disclosure
Attached is a copy of a press release being issued by the Company relating to
the Purchase and Sale Agreement, a copy of which is attached as Exhibit 99.6 and
is hereby incorporated.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits.
Number Exhibit
10.5 Consulting and Broker Agreement
99.6 Press Release announcing Consulting and Broker Agreement
2
© Edgar Online, source Glimpses